O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy

https://doi.org/10.1016/j.annonc.2020.04.054Get rights and content
Under an Elsevier user license
open archive

Cited by (0)